Bred heifers and adult cows, both beef and dairy |
|
|
-
•
Provides immunity against the beta and epsilon toxins in calves via colostral transfer
-
•
Enteric immunity from anti–beta toxin colostral antibody during the first 2 wk of life is critical in preventing disease from types B and C, because trypsin inhibitors in colostrum prevent denaturation of beta toxin
-
•
Systemic immunity from anti–epsilon toxin antibodies are effective at neutralizing systemically absorbed epsilon toxin and preventing neurologic signs from type D ± type B infections
|
|
|
-
•
C perfringens C and D toxoid vaccines are not designed to specifically stimulate an immune response against alpha toxin and usually are not considered effective at preventing abomasitis or enteritis caused by type A
-
•
May be particularly important in farms with a history of type A outbreaks in calves
-
•
Might also be useful in adult cows on dairies with a history of HBS
|
Feedlot cattle |
|
|
|
Beef and dairy calves (particularly from herds with previous C perfringens type C or D outbreaks) |
|
|
-
•
In cattle, classic type D disease most commonly observed in older, weaned animals on high-concentrate feed
-
•
Maternal antibodies may have decreased to nonprotective levels by this age
|
Adult sheep |
|
|
|
Bred ewes |
|
|
|
Lambs from vaccinated dams |
|
|
|
Lambs from unvaccinated dams or with suspected FPT |
|
|
|
Adult goats and kids |
|
|
-
•
May still only provide partial protection
-
•
Type D disease most common in goats, and is not prevented by 2 doses of multivalent ovine enterotoxemia vaccines
-
•
This may in part be caused by minimal antibody excretion into GI tract in localized enterocolitis in goats vs systemic antibody protection needed in sheep because of effects of absorbed epsilon toxin
|
Bred does |
|
|
— |